This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
The sources searched to identify primary studies were not reported.
Criteria used to ensure the validity of primary studies
The criteria used to ensure the validity of primary studies were not reported.
Methods used to judge relevance and validity, and for extracting data
Summary statistics from individual studies were used.
Number of primary studies included
At least 10 studies were used.
Methods of combining primary studies
Although reported narratively in the present study, the source studies from which estimates were derived were based on a systematic review of the literature in the derivation of risk factors associated with EOGBS and the effects of the intervention designed to prevent this disease. Studies were combined using the Mantel-Haentszel method
Investigation of differences between primary studies
An investigation of differences between primary studies was not reported.
Results of the review
Vaginal and rectovaginal colonisation rates were 14.7% and 22.8%, respectively. The overall attack rate was 3 cases per 1,000 live births. Intrapartum prophylaxis alone or in combination with postpartum prophylaxis reduced the EOGBS attack rate by 80.2% or by 95.0%, respectively, and postpartum prophylaxis alone reduced it by 68.8%.
Measure of benefits used in the economic analysis
The number of patients treated per 1,000 births and per case prevented, and the number of EOGBS cases prevented were used as the measures of benefit.
Direct costs
Direct costs were not discounted given the short time frame of the study (less than 1 year). Quantities and costs were reported separately. Direct costs covered the costs of maternal prophylaxis, costs of treating maternal complications, the cost of neonatal antibiotic prophylaxis, and the costs of screening tests. The quantity/cost boundary adopted was that of the hospital. The estimation of quantities and costs was based on actual data. Costs of screening tests were based on the costs of performing these tests at Lucile Packard Children's Hospital. The price year was not reported.
